Health
SARS‐CoV‐2‐mediated immune system activation and potential application in immunotherapy – Wiley
Although novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐mediated pulmonary inflammation has recently attracted great attention, its pathology…
1 INTRODUCTION
The novel coronavirus disease 2019 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV2), began in late December 2019 in Wuhan, China, thereafter spreading rapidly to other provinces; subsequently, it was identified in multiple other countries.1 The ability of SARSCoV2 to multitransmit rapidly, even when a person is asymptomatic, has made the global situation worse. The World Health Organization declared the pandemic a global health emergency of international…
Continue Reading
